Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 956 | 1,052 | 1,584 | 1,668 | 2,366 |
| Cost of Goods | 18 | 31 | 12 | 29 | 1,410 |
| Gross Profit | 938 | 1,021 | 1,572 | 1,639 | 956 |
| Operating Expenses | 4,087 | 3,104 | 3,743 | 2,997 | 2,615 |
| Operating Income | -3,131 | -2,052 | -2,159 | -1,329 | -1,249 |
| Interest Expense | 14 | 0 | 7 | 0 | 0 |
| Other Income | 271 | 120 | 82 | -258 | 333 |
| Pre-tax Income | -2,874 | -1,932 | -2,084 | -1,587 | -916 |
| Income Tax | 20 | N/A | N/A | -129 | N/A |
| Net Income Continuous | -2,894 | -1,932 | -2,084 | -1,458 | -1,311 |
| Net Income | $-2,894 | $-1,932 | $-2,084 | $-1,458 | $-1,311 |
| EPS Basic Total Ops | -1.96 | -1.60 | -1.72 | -2.00 | 1.00 |
| EPS Basic Continuous Ops | -2.44 | -1.59 | -1.72 | -1.53 | 0.62 |
| EPS Diluted Total Ops | -1.96 | -1.60 | -1.72 | -2.00 | 1.00 |
| EPS Diluted Continuous Ops | -2.44 | -1.59 | -1.72 | -1.53 | 0.67 |
| EBITDA(a) | $-3,160 | $-2,604 | $-2,615 | $-1,817 | $107 |